“…In contrast to FJ-drug interactions involving CYP3A substrates, decreased bioavailability of OATP2B1 substrates was observed with not only GFJ, but also OJ and AJ (Dresser et al, 2002;Lilja et al, 2004Lilja et al, , 2005Imanaga et al, 2011;Tapaninen et al, 2011;Jeon et al, 2013). Naringin, the main constituent flavonoid of GFJ, is thought to be a major inhibitor of OATP2B1-mediated drug transport in GFJ Shirasaka et al, 2009Shirasaka et al, , 2010aShirasaka et al, , b, 2011aShirasaka et al, , b, 2013 that in GFJ, it is unlikely that naringin is a major contributor to OATP2B1-mediated drug interactions involving OJ and AJ (Ameer et al, 1996;Ho et al, 2000).…”